Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meridian Bioscience Inc reaffirms FY 2014 guidance


Wednesday, 22 Jan 2014 07:30am EST 

Meridian Bioscience Inc:Reaffirmed FY 2014 guidance.Expects FY 2014 revenue in the range of $203-$208 mln.Expects FY 2014 EPS of $0.98 and $1.03.FY 2014 revenue of $203 mln and EPS of $0.99 - Thomson Reuters I/B/E/S. 

Company Quote

16.96
 +0.00%
19 Dec 2014